Repetitive ambulatory levosimendan as a bridge to heart transplantation
Revista Española de Cardiología (English Edition) · 2024
DOI: 10.1016/j.rec.2023.07.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Española de Cardiología (English Edition), 2024. Verfasst von Javier de Juan Bagudá und 22 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Cardiología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; C…. Hauptthemen laut MEDLINE: Heart Transplantation, Heart Failure, Pyridazines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION AND OBJECTIVES: Repetitive ambulatory doses of levosimendan are an option as a bridge to heart transplantation (HT), but evidence regarding the safety and efficacy of this treatment is scarce. The objective of the LEVO-T Registry is to describe the profile of patients on the HT list receiving levosimendan, prescription patterns, and clinical outcomes compared with patients not on levosimendan. METHODS: We retrospectively reviewed all patients listed for elective HT from 2015 to 2020 from 14 centers in Spain. RESULTS: A total of 1015 consecutive patients were included, of whom 238 patients (23.4%) received levosimendan. Patients treated with levosimendan had more heart failure (HF) admissions in the previous year and a worse clinical profile. The most frequent prescription pattern were fixed doses triggered by the patients' clinical needs. Nonfatal ventricular arrhythmias occurred in 2 patients (0.8%). No differences in HF hospitalizations were found between patients who started levosimendan in the first 30 days after listing and those who did not (33.6% vs 34.5%; P=.848). Among those who did not, 102 patients (32.9%) crossed over to levosimendan after an HF admission. These patients had a rate of 0.57 HF admissions per month before starting levosimendan and 0.21 afterwards. Propensity score matching analysis showed no differences in survival at 1 year after listing between patients receiving levosimendan and those who did not (HR, 1.03; 95%CI, 0.36-2.97; P=.958) or in survival after HT (HR, 0.97; 95%CI, 0.60-1.56; P=.958). CONCLUSIONS: Repetitive levosimendan in an ambulatory setting as a bridge to heart transplantation is commonly used, is safe, and may reduce HF hospitalizations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Cardiología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovascular…
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Unidad de Insuficiencia Cardíaca Avanzada y Trasplante, Servicio de Cardiología, Hospital Universitari de Bellvitge. BIOHEART-C…
- Unidad de Insuficiencia Cardíaca y Trasplante, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Servicio de Cardiología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Cor…
- Servicio de Cardiología, Hospital Clínic Universitari, Barcelona, Spain.
- Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Zitieren
APA
de Juan Bagudá, J., de Frutos, F., López-Vilella, R., Couto Mallón, D., Guzman-Bofarull, J., Blazquez-Bermejo, Z., Cobo-Belaustegui, M., Mitroi, C., Pastor-Pérez, F. J., Moliner-Abós, C., Rangel-Sousa, D., Díaz-Molina, B., Tobar-Ruiz, J., Salterain Gonzalez, N., García-Pinilla, J. M., García-Cosío Carmena, M. D., Crespo-Leiro, M. G., Dobarro, D., Almenar, L., …, & González-Costello, J. (2024). Repetitive ambulatory levosimendan as a bridge to heart transplantation. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2023.07.002
Vancouver
de Juan Bagudá J, de Frutos F, López-Vilella R, Couto Mallón D, Guzman-Bofarull J, Blazquez-Bermejo Z, et al. Repetitive ambulatory levosimendan as a bridge to heart transplantation. Revista Española de Cardiología (English Edition). 2024. doi:10.1016/j.rec.2023.07.002
BibTeX
@article{deJuanBagud2024,
author = {de Juan Bagudá, Javier and de Frutos, Fernando and López-Vilella, Raquel and Couto Mallón, David and Guzman-Bofarull, Joan and Blazquez-Bermejo, Zorba and Cobo-Belaustegui, Manuel and Mitroi, Cristina and Pastor-Pérez, Francisco J and Moliner-Abós, Carlos and Rangel-Sousa, Diego and Díaz-Molina, Beatriz and Tobar-Ruiz, Javier and Salterain Gonzalez, Nahikari and García-Pinilla, José Manuel and García-Cosío Carmena, María Dolores and Crespo-Leiro, María Generosa and Dobarro, David and Almenar, Luis and Delgado-Jiménez, Juan F and Paredes-Galán, Emilio and González-Vílchez, Francisco and González-Costello, José},
title = {Repetitive ambulatory levosimendan as a bridge to heart transplantation},
journal = {Revista Española de Cardiología (English Edition)},
year = {2024},
doi = {10.1016/j.rec.2023.07.002}
}
EUVIMED